Stemline Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
44,200.40
53,983.40
46,039.40
46,879.00
51,719.70
60,105.90
Total Accounts Receivable
199.60
-
298.70
34.50
149.80
843.40
Other Current Assets
292.90
1,636.80
353.20
256.20
175.40
2,109.60
Total Current Assets
44,693.00
55,620.20
46,691.30
47,169.70
52,044.90
63,058.90
Net Property, Plant & Equipment
383.30
230.00
95.70
22.50
136.70
222.40
Total Investments and Advances
40,204.90
4,644.80
51,428.60
20,923.80
14,468.40
-
Other Assets
-
-
-
3.10
356.20
212.30
Total Assets
85,281.20
60,495.00
98,215.60
68,119.10
67,006.20
63,493.60
Other Current Liabilities
5,013.80
4,473.80
9,455.50
10,253.80
19,838.90
Total Current Liabilities
5,013.80
4,473.80
9,455.50
10,253.80
19,838.90
Other Liabilities
643.00
608.00
648.20
142.20
96.80
Total Liabilities
5,656.80
5,081.80
10,103.70
10,396.00
19,935.70
Common Equity (Total)
79,624.40
55,413.20
88,112.00
57,723.10
47,070.40
Total Shareholders' Equity
79,624.40
55,413.20
88,112.00
57,723.10
47,070.40
Total Equity
79,624.40
55,413.20
88,112.00
57,723.10
47,070.40
Liabilities & Shareholders' Equity
85,281.20
60,495.00
98,215.60
68,119.10
67,006.20
About Stemline Therapeutics
View Profile
